1.646.889.1200|info@lifescipublicrelations.com

The Case for a Daily Self-Injection to Treat Hemophilia

/, News/The Case for a Daily Self-Injection to Treat Hemophilia

The Case for a Daily Self-Injection to Treat Hemophilia

We spoke to Nassim Usman, CEO of Catalyst, about the company’s approach to hemophilia, how its drugs work, and why he believes his company’s pipeline may provide better alternatives for hemophilia patients.

By | 2018-07-18T09:27:26-04:00 May 11th, 2018|listen, News|Comments Off on The Case for a Daily Self-Injection to Treat Hemophilia

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.